fashion -WSS

fashion

author：knowledge 2025-09-05 07:00:53 - browse：7115

In the center, three researchers examine a DNA helix. Two people stand in the front, one puts an apple into a capsule containing vegetables, the other holds a check list while standing next to a pile of medicines. On the right side, a scientist injects into mitochondria while another takes notes. A person behind the duo looks at a projection of a brain. On the left side, a client looks at a heart projection from a device held by a robot — biotech coverage from STAT — Adobe

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis.

But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca.

The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STAT Breakthrough Summit in San Francisco.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Chimpanzees, like humans and whales, get menopause: Study

WSS

Cassava reveals details — and problems — with Alzheimer's study

FDA warns J&J's Abiomed: We will regulate your software

Pharmacists can make shortage drugs, but at what cost?

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

NIH confirmation hearing shows politicization of research

The pink breast cancer awareness ribbon needs a redesign

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Researchers explore possible ties between long Covid, menopause

Trump demands the U.S. pay no more for drugs than other countries … again

Impact of Dobbs ruling felt at reproductive medicine meeting

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Alkermes shareholders re

Researchers explore possible ties between long Covid, menopause

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

explore

STAT Summit: Biotech founders on deal

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

First Opinion Podcast: Long Covid needs a new approach

FDA has safety concerns on CRISPR

Maker of FluMist seeks to allow at

Studies point to risks of excluding people with obesity from drug trials

Wikipedia

Wikipedia

explore

entertainment